We are live on ! Find out more
FBIO icon

Fortress Biotech

66 hedge funds and large institutions have $25.9M invested in Fortress Biotech in 2022 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 16 increasing their positions, 23 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

519% more call options, than puts

Call options by funds: $99K | Put options by funds: $16K

0.36% less ownership

Funds ownership: 2.27%1.91% (-0.36%)

16% less funds holding

Funds holding: 7966 (-13)

30% less repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 23

42% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 26

46% less capital invested

Capital invested by funds: $48.3M → $25.9M (-$22.4M)

Holders
66
Holders Change
-13
Holders Change %
-16.46%
% of All Funds
1.11%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
15
Increased
16
Reduced
23
Closed
26
Calls
$99K
Puts
$16K
Net Calls
+$83K
Net Calls Change
+$132K

FBIO Hedge Fund Activity: Q2 2022 in Review

66 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech (FBIO) for Q2 2022, worth a combined $25.9M — down 46% from $48.3M a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of FBIO and 15 opened new positions — a net loss of 11 holders — while 23 trimmed existing stakes and 16 added.

The largest buyer was Tang Capital Management, adding an estimated $981K. The largest seller was BlackRock, cutting an estimated $3.26M.

  • 66 institutional investors held Fortress Biotech (FBIO) as of Q2 2022, down from 79 in Q1 2022.
  • Funds reported $25.9M of Fortress Biotech stock for Q2 2022, down 46% quarter-over-quarter.
  • 15 funds opened new Fortress Biotech positions in Q2 2022 and 26 closed out, a net change of -11 holders.
  • The largest Fortress Biotech buyer in Q2 2022 was Tang Capital Management, an estimated $981K added.
  • The largest Fortress Biotech seller in Q2 2022 was BlackRock, an estimated $3.26M sold.

Based on aggregated 13F filings for Q2 2022.